HHS invests nearly $600 million in Moderna’s bird flu vaccine development
Posted: Jan 17, 2025
- Moderna is developing a vaccine to protect against bird flu strains H5 and H7
- The US Department of Health and Human Services is awarding $590 million to Moderna for vaccine development
- Moderna received $176 million in July 2023 for vaccine research
- The vaccine is based on mRNA technology and has shown positive results in earlier phases
- HHS Secretary Xavier Becerra emphasized the importance of accelerating vaccine development to stay ahead of avian flu variants
- The US is investing in monitoring bird flu and preparing for potential spread, including hospital preparedness and surveillance programs
- While most recent transmission has been among animals, the risk to the general public is low and there is no evidence of human-to-human spread from bird flu
Stay ahead of the market with AI stock alerts & AI summaries of the latest earnings, stock ideas for free with Fluid Bot. Sign up now!